Patient Profile 2: Patient Progression After Frontline HCC Therapy
Drs Saeed and Shroff discuss the next patient profile, focusing on HCC treatment strategies following disease progression after first-line therapy.
Source: onclive.com
Evolving Treatments News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Evolving Treatments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Evolving Treatments Today - Breaking & Trending Today
Combining Liver-directed and Systemic Therapies in HCC
The impact of compounding liver-directed and systemic therapies in HCC management is discussed by Drs Morse and Covey.
Source: onclive.com
HCC Treatment Strategy Driven by Real-World Evidence
Real-world evidence (RWE) provides critical knowledge for providers constructing a treatment regimen for patients diagnosed with hepatocellular carcinoma.
Source: onclive.com
IMBrave150 Study Overview
Dr Gong breaks down the structure and key takeaways from the IMBrave150 study.
Source: onclive.com
IMBrave-050 Study Overview
Dr Shroff breaks down the combination of atezolizumab and bevacizumab as outlined by the IMBrave-050 study.
Source: onclive.com